Editorial Response: The Role of Chlamydia pneumoniae in Atherosclerosis
The current state of knowledge regarding the role of Chlaspecimens, immunocytochemistry detected C. pneumoniae in mydia pneumoniae in atherosclerosis is that an association be-55% of the specimens, vs. 32% by PCR [3] . tween C. pneumoniae and atherosclerosis has been demonThe reason for the relative insensitivity of PCR is not comstrated, but it is unproven whether C. pneumoniae plays a role pletely understood but most likely involves tissue inhibitors of in the pathogenesis of atherosclerosis or its complications.
the reaction that are not eliminated by standard methods. Jantos In 1988, workers in Finland found C. pneumoniae antibody et al. state that this is unlikely in their study because of the more frequently in persons with coronary artery disease than use of nested PCR and internal controls and the spiking of in controls. Similar results were found by a large number of specimens with target DNA. Unfortunately, there is a lack of other investigators throughout the world, while some failed to detail in the Materials and Methods section concerning the find the association [1] . These seroepidemiological studies were amount of target DNA, the internal controls, and the results useful primarily in alerting us to the possibility of an associathat rule out inhibition. Problems with PCR inhibition have tion of C. pneumoniae with atherosclerosis and the diseases been seen in studies of tissue specimens unrelated to C. pneuthat it causes.
moniae. However, as Jantos et al. point out, the discrepant PCR results underscore the need for standardization of these assays See article by Jantos et al. on pages 988 -92.
for C. pneumoniae detection. The methods used for extraction of DNA from clinical specimens should also be standardized.
To this end, Dr. Jens Boman in Umea, Sweden, has spearThe crucial findings in demonstrating that there is an associaheaded a multilaboratory study for evaluation of differing PCR tion between C. pneumoniae and atherosclerosis are from studprotocols. ies of atherosclerotic tissue. The presence of C. pneumoniae
The condition of the specimens can also affect the frequency in atherosclerotic lesions has been demonstrated repeatedly by with which the organism is found. For example, atherectomy four different techniques: electron microscopy, isolation of the specimens are not ideal. They often provide only small amounts organism, PCR, and immunocytochemistry.
of tissue that may include considerable debris. One laboratory There are now over 20 reports from many areas of the world that originally reported a very low percentage of PCR-positive of studies in which the organism has been found by one or more atherectomy specimens [4] has recently reported a series of 17 of these techniques in atheroma of coronary, carotid, and femoral/ carotid endarterectomy specimens studied by both PCR and popliteal arteries and the aorta. The reports have shown a wide variation in the frequency of finding the organism in atheroscleimmunocytochemistry. While only 2 were positive by PCR, rotic lesions. While some of the variation may be due to the for 15 of 17 there was some evidence of C. pneumoniae in the source of specimens, the nature of the tests used and the expertise lesion, as revealed by immunocytochemistry with monoclonal of the investigators are the most important. Those investigators antibodies [5] . who used immunocytochemistry or direct staining techniques Jantos and colleagues propose that the immunocytochemical found from Ç40% to 100% of the lesions to be positive for reactions may not be true-positives but due to nonspecific reac-C. pneumoniae. Investigators using PCR found only about zero tivity with components of the atherosclerotic tissue. This explato 60% to be positive. The article by Jantos et al. reports results nation is highly unlikely for a number of reasons. Adjacent at the low end of this frequency [2] .
tissue sections are stained with an irrelevant antibody, such as In our nine reported tissue studies of a total of 362 persons normal mouse ascitic fluid, to specifically rule out that staining from diverse populations, we used both PCR and immunocytois due to a nonspecific reaction. Monoclonal antibodies, both chemistry. The organisms were found in lesions in young perChlamydia genus -specific and C. pneumoniae -specific, are sons as well as in extensive disease in older persons. Overall, used. In our studies, none of the tissues that stained positive 54% of the developed lesions were positive for C. pneumoniae.
with either the genus-or the species-specific antibody reacted The organism was not found in normal artery specimens. The with a Chlamydia trachomatis -specific antibody. Positive frequency of positives was invariably greater with use of immustaining of ''histologically normal'' arterial tissue with chlanocytochemistry. For example, in our study of atherectomy mydial antibodies is rare. When different segments of a single atherosclerotic plaque are examined, it is not uncommon that some segments are positive and some negative [6] . The immunocytochemical ob-Isolation of C. pneumoniae from an atheroma has been difficult, progress. Demonstrating the organism's role in the pathogenesis of atherosclerosis will not be easy and will not come from and until recently only two groups had reported single isolates, one from coronary and one from carotid artery lesions. Maass et a single experiment. This is a question of great importance because of the possibility of treatment or prevention of the al. isolated C. pneumoniae from 11 of 50 specimens of coronary artery or bypass vessels from open-heart surgery [7] . number one cause of death. In situ hybridization so far has not been a useful technique When we state that the association of C. pneumoniae and atherosclerosis has been proven beyond a reasonable doubt, it
